APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 34 filers reported holding APPLIED DNA SCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $4,000 | -60.0% | 20,000 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $10,000 | -28.6% | 20,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $14,000 | +75.0% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $8,000 | -73.3% | 20,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $30,000 | +20.0% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $25,000 | -13.8% | 20,000 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $29,000 | -9.4% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $32,000 | -43.9% | 20,000 | 0.0% | 0.00% | -66.7% |
Q3 2017 | $57,000 | +62.9% | 20,000 | 0.0% | 0.01% | +100.0% |
Q2 2017 | $35,000 | +6.1% | 20,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $33,000 | -10.8% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $37,000 | -38.3% | 20,000 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $60,000 | -7.7% | 20,000 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $65,000 | -5.8% | 20,000 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $69,000 | +6.2% | 20,000 | 0.0% | 0.01% | +20.0% |
Q4 2015 | $65,000 | -14.5% | 20,000 | 0.0% | 0.01% | -28.6% |
Q3 2015 | $76,000 | – | 20,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVI Holdings, LLC | 494,463 | $623,000 | 0.78% |
SABBY MANAGEMENT, LLC | 277,319 | $349,000 | 0.05% |
CHASE INVESTMENT COUNSEL CORP | 77,563 | $97,000 | 0.05% |
Benchmark Capital Advisors | 50,000 | $63,000 | 0.05% |
Quadrant Private Wealth Management, LLC | 20,000 | $25,000 | 0.02% |
BREWIN DOLPHIN LTD | 82,969 | $104,541 | 0.01% |
REILLY FINANCIAL ADVISORS, LLC | 50,000 | $63,000 | 0.01% |
EXENCIAL WEALTH ADVISORS, LLC | 23,700 | $30,000 | 0.01% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 12,577 | $16,000 | 0.01% |
IHT Wealth Management, LLC | 11,745 | $15,000 | 0.00% |